Cassava-based foods are staples enjoyed by millions of people around the world. From Brazil, Venezuela, Colombia, Ecuador, to ...

Cassava Sciences (SAVA) stock falls as the company halts Alzheimer's drug program after trial failures. Read more here.

Cassava Sciences has officially stopped the development of its investigational drug simufilam in Alzheimer’s disease after it failed to show benefit in a second Phase III trial. The company is ...

The UK-headquartered Cassava said the move was part of its plan to build an 'AI factory' in Africa to offer AI-driven computing services to digital businesses on the continent.